Developing high affinity antibodies as diagnostics

Abstract

The success of diagnostic reagents in the market today is measured by their level of specificity, affinity and stability. In the case of antibodies which represent approximately 30% of the global diagnostic market, the majority of molecules isolated from naïve or synthetic libraries have low affinities in the micromolar range which are not sufficient for diagnostic applications.